Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients-Reference-Cited by-同舟云学术

Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients

Published:2018-09-24 Issue:1 Volume:75 Page:13-20
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Dannenberg Lisa,Petzold Tobias,Achilles Alina,Naguib David,Zako Saif,Helten Carolin,M‘Pembele René,Mourikis Philipp,Podsvyadek Yanina,Grandoch Maria,Levkau Bodo,Zeus Tobias,Kelm Malte,Hohlfeld Thomas,Polzin Amin

Funder

Medical Faculty of the Heinrich-Heine-University Düsseldorf

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s00228-018-2560-z/fulltext.html

Reference46 articles.

1. Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C (2006) Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 113(25):2906–2913

2. Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 27(6):411–420

3. Arellano F, Sacristan JA (1990) Metamizole: reassessment of its therapeutic role. Eur J Clin Pharmacol 38(6):617–619